Lupus Foundation of America Seeks Proposals for Research Studies on Childhood Lupus and Stem Cell Trans... ( WASHINGTON June 22 -- The Lupus Foun...)

Navigation Links

Biology News Medicine News Biology Products Medicine Products Biology Definition Medicine Definition Biology Technology Medicine Technology Biology Dictionary Medicine Dictionary

HOME >> MEDICINE >> NEWS

Lupus Foundation of America Seeks Proposals for Research Studies on Childhood Lupus and Stem Cell Transplantation

Date:6/22/2009

WASHINGTON, June 22 /PRNewswire-USNewswire/ -- The Lupus Foundation of America (LFA) is seeking proposals for grant funding for research studies on lupus, an unpredictable and potentially fatal autoimmune disease. Grants will support areas of study in pediatric lupus and adult stem cell transplantation. The purposes of the studies are to advance adult stem cell transplantation research in humans as a treatment for lupus and address key understanding of pediatric/adolescent lupus research issues.

This is the second year of funding for the Michael Jon Barlin Pediatric Lupus Program. There is a special urgency associated with research on pediatric lupus, as lupus in children may develop early and tends to be more severe with multi-organ system involvement. Early and aggressive treatment can have a dramatic, positive impact on disease activity and on the progression of disease. Therefore, new diagnostic and prognostic tests, as well as treatments specifically for children, are more important than ever in addressing this potentially devastating form of lupus.

Stem cells are undifferentiated adult or embryonic cells that give rise to specialized cells, such as blood, bone, heart, etc. While stem cell transplantations are currently being tested and explored in clinics and labs, researchers are only beginning to understand the potential impact and role of adult stem cells in the development and treatment of lupus.

Binding letters of intent must be submitted by July 13, 2009 (extended from July 3). Online applications must be submitted by August 7, 2009. Awards will be announced on September 18, 2009. For additional information, visit the research section of the LFA website at lupus.org.

Although basic science and therapeutic advances are being made, substantial work remains to fully understand the causes, epidemiology, and clinical impact of lupus. The purpose of these grants is to accelerate resea
'/>"/>

SOURCE Lupus Foundation of America
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2
Related medicine news :

1. Anxiety and depression lower quality of life in majority of systemic lupus erythematosus patients
2. Novel DNA vaccine leads to kidney damage prevention in systemic lupus erythematosus models
3. Walk for Lupus Now(TM) at the Orange County Great Park
4. Mary Wilson Brings the Crowd to Their Feet at the Sixth Annual Lupus Foundation of America Awards Gala
5. EHE International and the S.L.E. Lupus Foundation Celebrate Lupus Awareness Month in Rockefeller Plaza
6. Decrease in sense of smell seen in lupus patients
7. Father Breaks Cycling Record To Honor Daughters Fight Against Lupus
8. LFAGW to Offer Free Lupus Symposium on May 16 for Patients and Families
9. Birth Control Pills Linked to Lupus Risk
10. Oral contraceptives associated with increased risk of lupus
11. Gene May Explain Womens Heightened Lupus Risk

Post Your Comments:

(Date:11/25/2009)...e-USNewswire/--WhenmostpeopleheartheacronymTMJ,the...tientsthehelptheyneed.TMJstandsfortheTemporal-Mand...connectswithyourskull(temporalbone). ,, Themost...ithchewing,clickingorpoppingofthejaw.Butmanyothers...aches,fatigue,sleepdisturbances,irritability,aloss...

(Date:11/25/2009)...wswire/--Thanksgivingmealswillbedeliveredtoapproxi...eathankstoFaithInAction/VolunteerActionforAging,ap...fSCANHealthPlan.Formorethan17yearstheseorganizatio...nksgivingmealstoseniorsinneedinLongBeach,Lakewood,...ities. ,, "Ourwarmholidaymealsaredeliveredtopeo...

(Date:11/25/2009)...cancer who were treated with cisplatin-based chemo...urological side effects and Raynaud-like phenomena... according to a new study published online Novembe...ute . , Marianne Brydy, M.D., of the Department ...gen, Norway, and colleagues conducted a cross-sect...

(Date:11/25/2009)...umatoid arthritis, could help newly diagnosed diab...5 (HealthDay News) -- A drug commonly used to trea...now also shows some promise in helping patients ne... rituximab (Rituxan), helped patients keep produci...ase had destroyed some of their pancreatic beta ce...

(Date:11/25/2009)... MISSIONSkincare ®isproudtosupportGNC,seffort...nnualSt.Jude ThanksandGiving campaign,$1fromthepur...TM)LipBalm willbedonatedtoSt.Jude.Additionally,GNC...onatcheckoutatoneoftheir5,000+retaillocationsoratG...uringtheir2009 ThanksandGiving campaign. ,, "We...

Breaking Medicine News(10 mins):Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2 Health News:Type 1 Diabetes May Have a New Foe 2 Health News:Type 1 Diabetes May Have a New Foe 3 Health News:MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R) 2

[1] TMJ and Chiropractic Care: An Overall Wellness Approach [0] SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors [0] News brief: Long-term testicular cancer survivors at high risk for neurological side effects [1] Type 1 Diabetes May Have a New Foe [2] MISSION Skincare(R) Supports GNC's Efforts To Raise Money for St. Jude Children's Research Hospital(R)

...AS --Dr. Ercole Cavalieri and Dr. Eleanor Rogen of... Institute for Research in Cancer, located in Omah...ism by which breast and prostate cancer cells begi...cer. Ercole Cavalieri, D.Sc. and research collabor...

...HB 675 Bill Would Provide Access to Medigap as Add... Patients Who Qualify , , TALLAHASSEE, Fla., Marc...KF of Florida) praised Senator Thad Altman and Rep... renal disease (ESRD) patients under age 65 who ar...

...ELAND, March 16 DATATRAK International, Inc.,(Nas...ocused on global eClinical,solutions for the clini...,results for the fourth quarter and full year of 2...mproved to 80% for the three months ended December...

...lls in the hippocampus predicts who,ll get the dis...althDay News) -- A loss of cells in the hippocampu...a new study finds. , The research included 64 Alzh... or thinking problems. The Dutch team used MRI to ...

... already approved outside US, but not all experts ...rch 16 (HealthDay News) -- A new type of Botox dru...ucing forehead wrinkles, a new study finds. , The ...s from contracting, an effect that lasts for sever...

...O, Calif., March 16 Gary Troutman, a 51-year old ...exico resident to receive a RapidArc(TM) stereotac...he New Mexico Cancer Center in Albuquerque. The st...n,s tumor faster and more accurately than was poss...

Preventium is 'where the prevention of breast and prostate cancer begins'The National Kidney Foundation of Florida Commends Senator Thad Altman, Representative Ritch Workman for Co-Sponsoring 'Common Sense' Legislation Widely Hailed as 'Good for Patients, Good for Taxpayers, Good for Florida'DATATRAK International, Inc. Announces Fourth Quarter and Full Year Results for 2008 Alzheimer's Tied to Shrinkage in Brain Area Botox Alternative May Safely Smooth Forehead Lines New Mexico Doctors Now Treating Brain and Prostate Cancer With RapidArc Radiotherapy Technology

(Date:11/25/2009)...RegadoBiosciences,aprivatelyheldcompanyleadingthed...lagents,announcedthatDavidMazzo,PhD,CEOandPresiden...hCareConferenceattheNewYorkPalaceHotelinNewYorkCit...Tuesday,December1andwillincludeanoverviewoftheComp...am,theanticoagulantsystem,REG1.Thehealthcareindust...

(Date:11/25/2009)...stCall/--Abaxis,Inc.(Nasdaq: ABAX ),amedicalproduc...stems,announcedtodaythatClintSeverson,chairmanandc...erJaffrayHealthCareConferenceonWednesday,December2...orkPalaceHotelinNewYorkCity. ,, AboutAbaxis ,...bloodanalysissystemsforuseinanyveterinaryorhumanpa...

(Date:11/25/2009)...mpraPharmaceuticalsInc.todayannouncedthatPrabhavat...presentatthePiperJaffray21stAnnualHealthCareConfer...eHotelinNewYorkCity.Dr.Fernandeswillprovideanoverv...amsforthetreatmentofdrug-resistantpathogensincludi...oundedin2006,CempraPharmaceuticalsisaprivately-hel...

Breaking Medicine Technology:Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2 Cyberonics Announces Epilepsy Technology Collaborations 58767 1 Cyberonics Announces Epilepsy Technology Collaborations 58767 2 Cyberonics Announces Epilepsy Technology Collaborations 58767 3 Cyberonics Announces Epilepsy Technology Collaborations 58767 4 Webcast Alert 3A Modern Moms Meet Modern Science 58765 1 Yongye International Announces 2010 2012 Strategic Plan 14335 1 Yongye International Announces 2010 2012 Strategic Plan 14335 2 Yongye International Announces 2010 2012 Strategic Plan 14335 3 Yongye International Announces 2010 2012 Strategic Plan 14335 4 Yongye International Announces 2010 2012 Strategic Plan 14335 5

[0] Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 [0] Abaxis, Inc. to Present at the 21st Annual Piper Jaffray Health Care Conference [0] Cempra Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference

... 2007 /PRNewswire/ -- Bayer HealthCare,Pharmaceuti...,studies with Betaseron(R) (interferon beta-1b), p...ology,s (AAN) 59th Annual Meeting,demonstrating e...tient satisfaction with treatment in patients with...llectively, these studies highlight the important ...

...QPT: TSX Venture Exchange, EDMONTON, May 02, 2007 ...uest" or the "Company") Quest is pleased to provid...52 for the treatment,of prostate cancer. , Prostat...th in,American men with approximately 230,000 new ...tic modalities for localized prostate,cancer are a...

Other Medicine Technology:Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 2 Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 3 Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron 4 Quest PharmaTech's Prostate Cancer Program Update 2 Quest PharmaTech's Prostate Cancer Program Update 3

Studies Presented at Neurology Conference Highlight Early Efficacy,Long-Term Tolerability, and High Patient Satisfaction with,Betaseron Quest PharmaTech's Prostate Cancer Program Update

TME 66 S

TME 64 S

TME 60 S

...r individual indications. XCaliber covers a compre...novative composite plastic material, XCaliber is s...ter. This means it's easier to handle, easier to a...pre-assembled, packaged sterile, and ready to use ...

Medicine Products:

TME 66 S TME 64 S TME 60 S Periarticular Hybrid Fixator

Lupus Foundation of America Seeks Proposals for Research Studies on Childhood Lupus and Stem Cell Trans...( WASHINGTON June 22 -- The Lupus Foun...),Health